Mall operator Simon Property profit drops as coronavirus hammers retailers

·

·

Mall operator Simon Property profit drops as coronavirus hammers retailers

(Reuters) – Simon Property Group (SPG.N) reported a 20.2% decline in quarterly profit and scrapped it annual forecast on Monday as the mall operator was forced to temporarily close all its U.S. retail properties in March due to the COVID-19 pandemic.
See Original Article

MyoKardia's Heart Drug Shines in Phase 3, FDA Filing Planned for 2021

An experimental MyoKardia drug developed to treat an inherited cardiovascular condition that restricts blood flow is showing it can improve on the symptoms of this condition as well as the heart’s ability to function. MyoKardia (NASDAQ: MYOK) is testing its …
See Original Article

Arizona restaurants reopen: Old Town Scottsdale restaurants, bars are 'excited to be back'

Gov. Doug Ducey is allowing restaurants to reopen their dining rooms beginning Monday. He has stressed that customers should limit their time in any establishment, however, as Arizona’s stay-at-home order remains in place through Friday, May 15. Arizona …
See Original Article

Mylan NV (MYL) Q1 2020 Earnings Call Transcript

Mylan N.V. (NASDAQ:MYL) Q1 2020 Earnings Call May 11, 2020, 10:30 a.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants. Prepared Remarks: Operator. Good day. My name is Erica, and I will be your conference operator today.
See Original Article

French drug maker Genfit says NASH drug fails late-stage clinical trial

French drug maker Genfit said Monday that its lead drug, elafibranor, failed to improve outcomes for patients with the fatty liver disease NASH, according to an interim analysis of a late-stage clinical trial. “These results are highly disappointing,” Genfit CEO …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.